Alaska Air vs Delta Air Lines
ALK and DAL side by side, both in air transportation, scheduled, and air courier. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ALK and DAL compare
Delta Air Lines is the larger company, worth 13 times as much as Alaska Air ($52.7B against $4.0B).
Delta Air Lines grew revenue faster over the last twelve months (14.1% versus 9.8% for Alaska Air).
Delta Air Lines keeps more of each dollar of sales as profit, with a net margin of 4.6% compared with −1.2% at Alaska Air.
Delta Air Lines pays a dividend yielding 1.0%; Alaska Air does not pay one.
Delta Air Lines scores higher on the StockData Score (10 against 6 for Alaska Air), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ALK | DAL |
|---|---|---|
| Size and price | ||
| Market cap | $4.0B | $52.7B |
| Share price | $35.71 | $80.15 |
| Change, 1 year | −14.5% | 36.4% |
| Change, 5 years | −39.8% | 81.0% |
| Beta (5Y) | 1.08 | 1.28 |
| Employees | 36K | 103K |
| StockData Score | ||
| Total score | 6 | 10 (better) |
| Valuation score | 3 (better) | 1 |
| Growth score | 3 (better) | 2 |
| Performance score | 0 | 3 (better) |
| Health score | 0 | 2 (better) |
| Dividend score | 0 | 2 (better) |
| Valuation | ||
| P/E | – | 16.0× |
| P/S | 0.3× (better) | 0.7× |
| P/B | 1.1× (better) | 2.3× |
| EV/EBITDA | 12.5× | 7.8× (better) |
| PEG | – | 0.29 |
| Fair value | $77.28 | $71.35 |
| Margin of safety | 53.8% (better) | −12.3% |
| Growth | ||
| Revenue growth (TTM) | 9.8% | 14.1% (better) |
| Revenue growth, 5Y average | 31.9% (better) | 30.0% |
| Net income growth (TTM) | −156% | −28.9% (better) |
| EPS growth (TTM) | −164% | −29.4% (better) |
| Profitability | ||
| Operating margin | −1.5% | 7.4% (better) |
| Net margin | −1.2% | 4.6% (better) |
| Return on equity | −4.6% | 15.9% (better) |
| Return on invested capital | −2.6% | 13.2% (better) |
| Financial health | ||
| Debt / equity | 1.65 | 0.54 (better) |
| Net debt / EBITDA | 5.75 | 1.06 (better) |
| Interest coverage | −0.7× | – |
| Current ratio | 0.55 (better) | 0.40 |
| Altman Z-score | 0.93 | 1.50 (better) |
| Piotroski F-score | 4 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 1.0% |
| Payout ratio | – | 15.7% |
| Years of dividend growth | – | 3 |
| Dividend growth, 5Y average | – | 11.0% |
| Buyback yield | 7.2% | – |
| Shareholder yield | 7.2% (better) | 1.0% |
| Ownership | ||
| Held by institutions | 92.1% | 88.3% |
| Held by insiders | 0.72% | 0.55% |
| Insider net buying, 12 months | −$2.5M (better) | −$122M |
| Superinvestors holding | 1 | 4 (better) |
| Short interest, % of float | 10.9% | 3.9% |
Go deeper
- ALK stock overview
- ALK income statement
- ALK valuation and score
- DAL stock overview
- DAL income statement
- DAL valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.